BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Using AI to Discover Dual-purpose Therapeutics Targeting Aging and
  Disease at the same time - Alex Zhavoronkov\, PhD - Insilico Medicine
DTSTART:20221126T130000Z
DTEND:20221126T140000Z
UID:TALK192962@talks.cam.ac.uk
CONTACT:Brandon Spencer Lockey
DESCRIPTION:Insilico Medicine is a leader in next generation artificial in
 telligence technologies for drug discovery and biomarker development. They
  have raised over $415 million in multiple rounds\, nominated 8 preclinica
 l candidates and entered human clinical trials with an AI-discovered and A
 I-designed antifibrotic\, and recently struck a deal with Sanofi worth up 
 to $1.2 billion.  Alex is an adjunct professor of artificial intelligence 
 at the Buck Institute for Research on Aging and has published over 160 pee
 r-reviewed academic publications and two books since 2014\, and has pledge
 d his commitment to the Longevity Field.\n\nhttps://us02web.zoom.us/meetin
 g/register/tZAqcuioqTMqGtZhgBH5SVpxOy8nbL910ILV 
LOCATION:Virtual Talk (Zoom)
END:VEVENT
END:VCALENDAR